« Previous
Next »
Nutrition
Volume 21, Issue 10
, Pages 994-1002
, October 2005
Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression
References
- . Plasma homocysteine, a risk factor for vascular disease (plasma levels in health, disease, and drug therapy) . J Lab Clin Med . 1989;114:473–501
- . Hyperhomocysteinemia (an independent risk factor for vascular disease) . N Engl J Med . 1991;324:1149–1155
- . Homocyst(e)ine (an important risk factor for atherosclerotic vascular disease) . Curr Opin Lipidol . 1997;8:28–34
- . Homocysteine and atherothrombosis . N Engl J Med . 1998;338:1042–1050
- . Homocysteine and coronary atherosclerosis . J Am Coll Cardiol . 1996;27:517–527
-
.
Vascular endothelium
(an integrator of pathophysiologic stimuli in atherosclerosis)
.
Am J Cardiol
. 1995;75:67–70
-
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
.
Proc Natl Acad Sci USA
. 1991;88:5252–5256
-
.
Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells. Implications for vascular disease
.
Circulation
. 2001;103:2717–2723
- . Homocysteine provokes leukocyte–endothelium interaction by downregulation of nitric oxide . Gen Pharmacol . 1999;33:487–498
- . The pathogenesis of atherosclerosis (a perspective for the 1990s) . Nature . 1993;362:801–809
- . Mechanisms of disease (atherosclerosis - an inflammatory disease) . N Engl J Med . 1999;340:115–126
- . Is atherosclerosis an immunologically mediated disease? . Immunol Today . 1995;16:27–33
- . Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque . Arteriosclerosis . 1986;6:131–138
- . Atherosclerotic lesions in humans (in situ immunophenotypic analysis suggesting an immune mediated response) . Lab Invest . 1989;61:166–170
- . Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity . Immunol Lett . 1988;19:183–191
- . The role of macrophage- and dendritic cell-derived IL12 in Th1 phenotype development . Res Immunol . 1995;146:466–472
- MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions . Nature . 1999;398:718–723
- . Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis . Br Heart J . 1993;69:S30–S37
- . Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall . Atherosclerosis . 1996;127:263–271
- . Regulation of the immune response by macrophage migration inhibitory factor (biological and structural features) . J Mol Med . 1998;76:151–161
- . Macrophage migration inhibitory factor (MIF) (mechanisms of action and role in disease) . Microbes Infect . 2002;4:449–460
- . Uromodulin and Tamm-Horsfall protein induce human monocytes to secrete TNF and express tissue factor . J Immunol . 1997;158:3449–3456
- . Identification of macrophage migration inhibitory factor (MIF) in human skin and its immmunohistochemical localization . FEBS Lett . 1996;381:199–202
- MIF is a pituitary- derived cytokine that potentiates lethal endotoxaemia . Nature . 1993;365:756–759
- . The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor . J Exp Med . 1994;179:1895–1902
- . Induction of monocytes tissue factor expression by homocysteine (a possible mechanism for thrombosis) . Blood . 2000;96:966–972
- . Hyperhomocysteinemia and thrombosis (acquired conditions) . Thromb Haemost . 1997;78:527–531
- . Cytokine mediators of immunity and inflammation . Arch Surg . 1993;128:1235–1241
- . Chemokines . Blood . 1997;90:909–928
- . Initiation of acute phase response and synthesis of cytokines . Biochim Biophys Acta . 1996;1317:84–94
- . Correlating functional staging to effective treatment of acute surgical illness . Am J Surg . 2001;182:278–286
- . Phagocytosis of neutrophil polymorphonuclears by macrophages in human bone marrow (importance in granulopoiesis) . J Clin Pathol . 1980;33:1110–1113
- . Phagocytosis of blood cells by splenic macrophages in thrombotic thrombocytopenic purpura . Ann Intern Med . 1975;82:799–802
- . Endothelial cells and atherosclerosis (lipoprotein metabolism, matrix interactions, and monocyte recruitment) . Curr Opin Lipidol . 1994;5:316–322
- . Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis . Toxicol Pathol . 1990;18:560–571
- . Human endothelium as a source of multifunctional cytokines (molecular regulation and possible role in human disease) . J Interferon Cytokine Res . 1999;19:91–104
-
.
Pathogenesis of plaque disruption
.
In:
Fuster V
, Ross R
, Topol EJ
editor.
Atherosclerosis and coronary artery disease
. Volume 2:
Philadelphia: Lippincott-Raven; 1996;p. 492–510
- . The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions . Am J Pathol . 1981;103:181–190
- . Homocysteine and arterial occlusive disease (a concise review) . Cardiologia . 1999;44:341–345
- . Vascular pathology of homocystinemia (implications for the pathogenesis of arteriosclerosis) . Am J Pathol . 1969;56:111–128
- . Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia . J Clin Invest . 1996;98:24–29
- . Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells . Atherosclerosis . 2002;161:365–374
-
Homocysteine inhibits tumor necrosis factor-induced activation of endothelium via modulation of nuclear factor-kappa b activity
.
Biochim Biophy Acta
. 2001;1540:154–165
- . Homocysteine decreases endothelin-1 production by cultured human endothelial cells . Eur J Biochem . 1999;263:367–376
- . White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men . Arterioscler Thromb Vasc Biol . 1996;16:499–503
- . Neutrophil-induced erythrocyte injury (a potential cause of erythrocyte destruction in the anemia associated with inflammatory disease) . Vet Pathol . 1988;25:450–455
- . Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies . Circulation . 1991;83:836–844
- . Macrophage migration inhibitory factor . Crit Care Med . 2002;30:s27–s35
- . The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor . J Exp Med . 1994;179:1895–1902
- . Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4–producing Th cells . J Exp Med . 1993;177:1199–1204
- A definition of initial, fatty streak, and intermediate lesions of atherosclerosis (a report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association) . Circulation . 1994;89:2462–2478
This study was supported by the National Science Council, Executive Yuan, Taiwan (grants NSC 87-2314-B037-008, NSC 89-2320-B037-069, NSC 91-2314-B-037-270, and KMU-M9317).
PII: S0899-9007(05)00198-X
doi: 10.1016/j.nut.2005.01.011
© 2005 Elsevier Inc. All rights reserved.
« Previous
Next »
Nutrition
Volume 21, Issue 10
, Pages 994-1002
, October 2005
